AzTrials
AzTrials

Pediatric ObesityOBESOMACNCT02588469

Exercise and Venous Compression on Upper Airway Resistance in Obese Teenagers With OSA

A study testing Interventional group in people with Pediatric Obesity and Sleep Apnea, Obstructive, run by Centre Hospitalier Universitaire de Besancon at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to assess the effects of physical exercise, associated or not with venous compression of the leg, on obstructive sleep apnea (OSA) severity and upper airway resistance in obese teenagers. Read more about this study

Who is it for?
Ages 12 to 17 years
Conditions the study is for
Pediatric Obesity, Sleep Apnea, Obstructive
What is being tested?
Interventional group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 siteFrance
Study dates
27 Aug 2015to Jun 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Obese adolescents (BMI > 97th percentile),
  • patients aged from 12 to 17 years old, (born between 07/01/2003 and 09/01/1197),
  • enrolled in a pediatric obesity center with diet and physical activity programs and psychological management,
  • without observed tonsils hypertrophy (Mallampati and Friedman scores),
  • without contraindication for bioimpedance analysis, acoustic method and stain gauge plethysmography,
  • with physical activity certificate issued by a cardiologist
  • covered by the national insurance scheme of his/her legal representative,
  • having signed, as well as his(her) legal representative, the informed consent of participation.

Who cannot join

  • Non obese adolescents (BMI < 97th percentile)
  • patients aged under 12 or over 17 years old,
  • not enrolled in a pediatric obesity center with diet and physical activity programs and psychological management,
  • with observed tonsils hypertrophy (Mallampati and Friedman scores),
  • with contraindication for bioimpedance analysis, acoustic method and stain gauge plethysmography,
  • without physical activity certificate issued by a cardiologist
  • uncovered by the national insurance scheme of his/her legal representative,
  • not having signed, as well as his(her) legal representative, the informed consent of participation.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Centre de soins de suite et de réadaptation La Beline

    Salins-les-Bains, 39110

Other trials in France

About this study

Official title: Effects of Exercise and Venous Compression on Upper Airway Resistance in Obese Teenagers With Obstructive Sleep Apnea Syndrome

The purpose of this study is to assess the effects of physical exercise, associated or not with venous compression of the leg, on obstructive sleep apnea (OSA) severity and upper airway resistance in obese teenagers. Half of the participants will undergo physical exercise and compression socks program, and the other half of subjects will undergo physical exercise program without compression socks.

Read the detailed description

Obesity is an important factor of OSA development in children and teenagers, and physical activity is a relevant alternative to promote OSA decrease with ou without weight loss.

Physical activity, beyond the improvement of body composition and exercise cardiorespiratory capacity, restricts fluid retaining in the lower limb of the leg by the activation of musculovenous pump. Fluid retaining is involved in OSA severity because of nocturnal fluid shift from legs to rostral zone which promotes pharyngeal oedema development and upper airway collapsibility.

It has been previously shown that venous compression leads to beneficial fluid regulation in OSA subjects and appears as an efficient tool in OSA management.

To the investigators knowledge no study assess the impact of the cumulative effect of physical and venous compression program on upper airway resistances in obese teenager with OSA.

Being tested
Interventional group, Control group
Keywords
pediatric obesity, obstructive sleep apnea, physical exercise, compression socks, rostral fluid shift
Medical subject headings
Pediatric Obesity, Sleep Apnea, Obstructive, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Interventional groupOther

    Venous compression leads to beneficial fluid regulation in OSA participants and appears as an efficient tool in OSA management.

    To the investigators knowledge no study assess the impact of the cumulative effect of physical and venous compression program on upper airway resistances in obese teenager with OSA.

  • Control groupOther

    Standard obesity care with physical activity program

Study groups in NCT02588469
Study groupRoleWhat they receive
Interventional groupExperimentalPhysical activity program coupled with compression socks wearing during 3 months.
Receives: Other: Interventional group
control groupActive comparatorPhysical activity program without compression socks during 3 months.
Receives: Other: Control group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from Obstructive sleep apnea severity at 3 months.

    Obstructive Sleep Apnea change will be assessed with polysomnography system at baseline and after three months

    Measured: This study includes 2 assessments : baseline (T0) and 3 months (T3)

Secondary outcomes (10)
  1. Upper airway resistances

    upper airway resistance will be assessed by acoustic method

    Measured: This study includes 2 assessments : baseline (T0) and 3 months (T3)

  2. Fluid shift

    fluid shift will be assessed by bioimpedance analysis

    Measured: This study includes 2 assessments : baseline (T0) and 3 months (T3)

  3. Calf and neck circumferences

    Calf and neck circumferences will be assessed with nonelastic tape

    Measured: This study includes 2 assessments : baseline (T0) and 3 months (T3)

  4. Calf and neck circumferences

    Calf and neck circumferences will be assessed by plethysmography

    Measured: This study includes 2 assessments : baseline (T0) and 3 months (T3)

  5. Anthropometric parameters

    weight, height, waist and hip circumferences (body weight scale, standing stadiometer and non-elastic tape)

    Measured: This study includes 2 assessments : baseline (T0) and 3 months (T3)

  6. Body composition

    fat mass, fat free mass ( by bioimpedance analysis)

    Measured: This study includes 2 assessments : baseline (T0) and 3 months (T3)

  7. Pulmonary function during exercise

    Incremental maximal exercise in cycling ergometer with respiratory gas assessment (metamax)

    Measured: This study includes 2 assessments : baseline (T0) and 3 months (T3)

  8. Metabolic responses

    Glucose, LDL-Cholesterol, HDL-Cholesterol, Total Cholesterol, Triglycerides (ELISA and RIA technics)

    Measured: This study includes 2 assessments : baseline (T0) and 3 months (T3)

  9. Hormonal responses

    Insulin, leptin, adiponectin, catecholamines (ELISA and RIA technics)

    Measured: This study includes 2 assessments : baseline (T0) and 3 months (T3)

  10. Inflammatory responses

    C-reactive protein (ELISA and RIA technics)

    Measured: This study includes 2 assessments : baseline (T0) and 3 months (T3)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Oct 2015 (estimated)
  2. Study start27 Aug 2015
  3. Primary completionJun 2016
  4. Study completionJun 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02588469
Sponsor's protocol ID
P/2015/250
Acronym
OBESOMAC
Status last verified
Jan 2018
First submitted
22 Jul 2015
Last updated
24 Jan 2018
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Roche J, Corgosinho FC, Damaso AR, Isacco L, Miguet M, Fillon A, Guyon A, Moreira GA, Pradella-Hallinan M, Tufik S, Tulio de Mello M, Gillet V, Pereira B, Duclos M, Boirie Y, Masurier J, Franco P, Thivel D, Mougin F. Sleep-disordered breathing in adolescents with obesity: When does it start to affect cardiometabolic health? Nutr Metab Cardiovasc Dis. 2020 Apr 12;30(4):683-693. doi: 10.1016/j.numecd.2019.12.003. Epub 2019 Dec 16.

    PubMed 32008915
  • Roche J, Gillet V, Perret F, Mougin F. Obstructive Sleep Apnea and Sleep Architecture in Adolescents With Severe Obesity: Effects of a 9-Month Lifestyle Modification Program Based on Regular Exercise and a Balanced Diet. J Clin Sleep Med. 2018 Jun 15;14(6):967-976. doi: 10.5664/jcsm.7162.

    PubMed 29852904

Questions about this trial

What is this clinical trial studying?

A study testing Interventional group in people with Pediatric Obesity and Sleep Apnea, Obstructive, run by Centre Hospitalier Universitaire de Besancon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Jan 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from Obstructive sleep apnea severity at 3 months. (time frame: This study includes 2 assessments : baseline (T0) and 3 months (T3)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02588469, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jan 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in